Mylan seeks nod for two biosimilars

Mylan seeks nod for two biosimilars

  • Nov 07 2017, 21:16 ist
  • updated: Nov 08 2017, 01:20 ist

Biotechnology firm Biocon said its partner Mylan has re-submitted marketing authorisation applications with the European drug regulator European Medicines Agency for two biosimilars Trastuzumab and Pegfilgrastim, reports PTI from New Delhi.

Get a round-up of the day's top stories in your inbox

Check out all newsletters

Deccan Herald News now on Telegram - Click here to subscribe

Follow us on Facebook | Twitter | Dailymotion | YouTube

Get a round-up of the day's top stories in your inbox

Related videos

What's Brewing

Ode to Sparrows: One for the bird, one for the word

Ode to Sparrows: One for the bird, one for the word

6 cities that are reimagining urban life

6 cities that are reimagining urban life

Man comes from Kolkata to kill estranged wife in B'luru

Man comes from Kolkata to kill estranged wife in B'luru

10% Indians affected by chronic kidney disease

10% Indians affected by chronic kidney disease

Ugadi rush: Flower markets bloom amid festive fervour

Ugadi rush: Flower markets bloom amid festive fervour

Ingredients for life on Earth likely came from space

Ingredients for life on Earth likely came from space